113 related articles for article (PubMed ID: 3943588)
21. Eosinophil response in guinea pig skin to a low molecular weight eosinophil chemotactic factor extracted from livers of mice with schistosomiasis.
Tsuda S; Fukuyama K; Epstein WL
J Invest Dermatol; 1980 Apr; 74(4):216-8. PubMed ID: 7373075
[TBL] [Abstract][Full Text] [Related]
22. The formation of eosinophil and neutrophil chemotactic activity during a pollen season and after allergen challenge.
Håkansson L; Rak S; Dahl R; Venge P
J Allergy Clin Immunol; 1989 May; 83(5):933-9. PubMed ID: 2654257
[TBL] [Abstract][Full Text] [Related]
23. An eosinophil chemotactic lymphokine in the supernatant of lymphokine-activated killer (LAK) cell culture: relationship to interleukin-5.
Ishimitsu T; Torisu M
J Surg Res; 1993 Sep; 55(3):307-13. PubMed ID: 8412115
[TBL] [Abstract][Full Text] [Related]
24. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
Wardlaw AJ; Moqbel R; Cromwell O; Kay AB
J Clin Invest; 1986 Dec; 78(6):1701-6. PubMed ID: 3023451
[TBL] [Abstract][Full Text] [Related]
25. A review of eosinophil chemotaxis and function in Taenia taeniaeformis infections in the laboratory rat.
Potter K; Leid RW
Vet Parasitol; 1986 Mar; 20(1-3):103-16. PubMed ID: 3518212
[TBL] [Abstract][Full Text] [Related]
26. Neutrophil and eosinophil chemotactic factors in the excretory/secretory products of sheep abomasal nematode parasites: NCF and ECF in abomasal nematodes.
Reinhardt S; Scott I; Simpson HV
Parasitol Res; 2011 Sep; 109(3):627-35. PubMed ID: 21424403
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of levamisole against Ostertagia ostertagi in Louisiana cattle during maturation of inhibited larvae (September) and during minimal inhibition (December/January).
Williams JC; Knox JW; Marbury KS; Swalley RA; Eddi CS
Vet Parasitol; 1991 Oct; 40(1-2):73-85. PubMed ID: 1763492
[TBL] [Abstract][Full Text] [Related]
28. Larval migration inhibition activity in abomasal mucus and serum from calves infected with Ostertagia ostertagi.
Claerebout E; Agneessens ; Shaw DJ; Vercruysse J
Res Vet Sci; 1999 Jun; 66(3):253-7. PubMed ID: 10333468
[TBL] [Abstract][Full Text] [Related]
29. Dermal cellular responses of helminth-free and Ostertagia ostertagi-infected calves to intradermal injections of soluble extracts from O. ostertagi L3 larvae.
Cross DA; Klesius PH; Hanrahan LA; Haynes TB
Vet Parasitol; 1987 Feb; 23(3-4):257-64. PubMed ID: 3564354
[TBL] [Abstract][Full Text] [Related]
30. Generation and partial characterization of an eosinophil chemotactic cytokine produced by sensitized equine mononuclear cells stimulated with Strongylus vulgaris antigen.
Dennis VA; Klei TR; Chapman MR
Vet Immunol Immunopathol; 1993 Jul; 37(2):135-49. PubMed ID: 8236793
[TBL] [Abstract][Full Text] [Related]
31. Low molecular weight eosinophil chemotactic factor (ECF) production by rat peritoneal mononuclear phagocytes.
Czarnetzki BM
Immunobiology; 1980 Apr; 157(1):62-6. PubMed ID: 6782008
[TBL] [Abstract][Full Text] [Related]
32. Persistence of dead Ostertagia ostertagi in the abomasal mucosa following anthelmintic treatment.
Snider TG; Williams JC; Knox JW; Roberts ED; Romaire TL
Vet Rec; 1985 Jan; 116(3):69-72. PubMed ID: 3838393
[TBL] [Abstract][Full Text] [Related]
33. Identification of a novel and highly potent eosinophil chemotactic lipid in human eosinophils treated with arachidonic acid.
Morita E; Schröder JM; Christophers E
J Immunol; 1990 Mar; 144(5):1893-900. PubMed ID: 2155268
[TBL] [Abstract][Full Text] [Related]
34. Synergistic influence of Ostertagia ostertagi and Trichostrongylus axei on Ostertagia ostertagi larval inhibition and abomasal lesions in cattle.
Snider TG; Williams JC; Karns PA; Trammell HE; Romaire TL
Am J Vet Res; 1985 Aug; 46(8):1748-52. PubMed ID: 4037502
[TBL] [Abstract][Full Text] [Related]
35. Eosinophil and neutrophil chemotactic activities of adult worm extracts of Schistosoma japonicum in vivo and in vitro.
Horii Y; Owhashi M; Ishii A; Bandou K; Usui M
J Parasitol; 1984 Dec; 70(6):955-61. PubMed ID: 6098637
[TBL] [Abstract][Full Text] [Related]
36. Presence of factors chemotactic for granulocytes in hypereosinophilic syndrome sera: relation with alterations in eosinophil migration.
Gosset P; Prin L; Capron M; Auriault C; Tonnel AB; Capron A
Clin Exp Immunol; 1986 Sep; 65(3):654-63. PubMed ID: 3780047
[TBL] [Abstract][Full Text] [Related]
37. Effect of chemotactic agents on rat and guinea pig eosinophil cytotoxicity in vitro.
Musgrove NR; Cook RM
Int Arch Allergy Appl Immunol; 1988; 86(3):319-24. PubMed ID: 2841243
[TBL] [Abstract][Full Text] [Related]
38. Anisakis and eosinophil. I. Detection of a soluble factor selectively chemotactic for eosinophils in the extract from Anisakis larvae.
Tanaka J; Torisu M
J Immunol; 1978 Mar; 120(3):745-9. PubMed ID: 632586
[TBL] [Abstract][Full Text] [Related]
39. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice.
Rothenberg ME; Ownbey R; Mehlhop PD; Loiselle PM; van de Rijn M; Bonventre JV; Oettgen HC; Leder P; Luster AD
Mol Med; 1996 May; 2(3):334-48. PubMed ID: 8784786
[TBL] [Abstract][Full Text] [Related]
40. Effect of neutrophil-derived eosinophil chemotactic factor (ECF) in human and guinea pig skin.
Czarnetzki BM; Frosch PJ; Vakilzadeh F; Panneck WB
J Invest Dermatol; 1980 Feb; 74(2):109-11. PubMed ID: 7351498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
